Vivos Therapeutics
VVOS
VVOS
19 hedge funds and large institutions have $1.34M invested in Vivos Therapeutics in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$527K | |
| 2 | +$184K | |
| 3 | +$36.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$31.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.42K |
Top Sellers
| 1 | -$620K | |
| 2 | -$310K | |
| 3 | -$122K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$13.4K |
| 5 |
Morgan Stanley
New York
|
-$2.62K |
